Audiovisual 6 Tips to Avoid Medication Mistakes. Citation Text: Food and Drug Administration. Copy Citation Save Save to your library Print Share Facebook Twitter Linkedin Copy URL July 18, 2007 Food and Drug Administration. This Web site shares tips for consumers to help ensure safe use of medications. Information Save Save to your library Print Share Facebook Twitter Linkedin Copy URL Cite Citation Citation Text: Food and Drug Administration. Copy Citation Related Resources From the Same Author(s) Quick Tips for Buying Medicines Over the Internet. March 6, 2005 Drug Shortages. April 27, 2011 Reprocessing of Reusable Medical Devices. January 11, 2012 Safety Information on Alaris SE Infusion Pumps. November 15, 2006 Examples of Medical Device Misconnections. March 8, 2023 Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples. October 7, 2021 Fentanyl transdermal system (marketed as Duragesic) information. July 10, 2015 Human Factors and Medical Devices. March 27, 2005 Questions and Answers on FDA's Adverse Event Reporting System (FAERS). September 17, 2008 Bar code label requirement for human drug products and biological products. March 27, 2005 My Medicines. July 9, 2014 FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. June 20, 2018 FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. August 5, 2020 FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020 Luer Connector Misconnections: Under-Recognized but Potentially Dangerous Events. August 15, 2012 FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020 National Prescription Drug Take Back Day. April 16, 2023 FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework. April 30, 2014 Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff. August 5, 2015 Safe Use Initiative. November 18, 2009 FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam). June 3, 2015 MedWatch: The FDA Safety Information and Adverse Event Reporting Program. June 22, 2005 Shelhigh, Inc. implantable medical devices. May 2, 2007 Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018 FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved. January 13, 2016 OpenFDA. June 11, 2014 Be an Active Member of Your Health Care Team. May 21, 2014 Lock it Up: Medicine Safety in Your Home. November 30, 2011 BeSafeRx: Know Your Online Pharmacy. October 10, 2012 Teaching Kids About Using Medicine Safely. February 29, 2012 FDA MedWatch and Patient Safety Tutorial. December 10, 2008 FDA Patient Safety News. A Video News Show for Health Professionals. March 6, 2005 Postmarket Drug Safety Information for Patients and Providers. November 19, 2008 New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. September 29, 2010 Serious medication errors from intravenous administration of nimodipine oral capsules. August 11, 2010 MedWatch E-list. March 6, 2005 Medicines in My Home. August 2, 2006 Promethazine HCl (marketed as Phenergan) Information. May 3, 2006 Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. February 22, 2006 FDA/ISMP Safe Medication Management Fellowship Program. February 8, 2023 Accidental exposures to fentanyl patches continue to be deadly to children. July 21, 2021 Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020 Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products. November 23, 2005 Strategic Plan for Preventing and Mitigating Drug Shortages. November 13, 2013 Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. August 25, 2021 An Introduction to the Improved FDA Prescription Drug Labeling. November 1, 2006 Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry. January 9, 2013 Drug Shortages: Root Causes and Potential Solutions. November 13, 2019 Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health. June 6, 2018 SmartTots. April 13, 2011 Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. October 3, 2022 Interference between CT and Electronic Medical Devices. July 30, 2008 Bar Code Label Requirements for Blood and Blood Components. April 26, 2006 Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging. March 3, 2010 A Review of FDA’s Approach to Medical Product Shortages. November 16, 2011 FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication November 6, 2019 FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019 Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication. May 4, 2022 FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022 Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment. March 22, 2006 Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States. June 23, 2020 FDA Pharmacists Help Consumers Use Medicines Safely. November 19, 2014 Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry. December 23, 2020 Maalox Total Relief and Maalox Liquid Products: Medication Use Errors. March 3, 2010 Making Medical Devices Safer at Home. January 9, 2013 Safety Problems With Your Child's Medical Device? July 31, 2013 Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. April 8, 2009 Public Health Notification from FDA: Vail Products Enclosed Bed Systems. December 19, 2007 FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change. January 9, 2005 FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment. June 7, 2006 Nimodipine Capsules (marketed as Nimotop). March 1, 2006 Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry. May 25, 2022 Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. January 13, 2021 Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip). June 22, 2011 Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions. January 25, 2017 FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018 FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose. January 19, 2011 Relenza (zanamivir) inhalation powder. October 21, 2009 Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology. October 21, 2009 Tamiflu (oseltamivir) for oral suspension: potential medication errors. October 7, 2009 Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling. February 16, 2011 Infections associated with reprocessed flexible bronchoscopes. September 30, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. March 11, 2015 Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications. March 4, 2015 Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning. March 4, 2015 FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor). August 12, 2015 Important change to heparin container labels to clearly state the total drug strength. December 19, 2012 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death. October 9, 2013 Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion. May 15, 2013 Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays. November 7, 2012 Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume. May 30, 2012 FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021 Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021 ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien). November 19, 2008 Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022 FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020 Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling. May 19, 2021 Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. February 17, 2021 View More Related Resources ISMP's List of High-Alert Medications in Acute Care Settings. January 14, 2024 The hospital ran out of her child's cancer drug. Now she's fighting to end shortages. November 1, 2023 Medication guides: patient medication information. A proposed rule by the Food and Drug Administration. June 28, 2023 Speak Up [brochures]. May 1, 2023 FDA and ISMP Lists of Look-Alike Drug Names With Recommended Tall Man Letters. January 26, 2023 Accidental exposures to fentanyl patches continue to be deadly to children. July 21, 2021 Assessment of patient-preferred language to achieve goal-aligned deprescribing in older adults. June 30, 2021 Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. February 10, 2021 FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020 FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020 10 Medication Safety Tips for Hospitalized Patients. September 25, 2019 Get the Medications Right Institute. August 7, 2019 Medication Safety in Key Action Areas. July 10, 2019 Using a spare medication vial to store multiple medications: a potentially fatal in-home medication error. March 6, 2019 Visual acuity, literacy, and unintentional misuse of nonprescription medications. June 13, 2018 Communicating Clearly About Medicines: Proceedings of a Workshop. September 20, 2017 All consumer medication information is not created equal: implications for medication safety. April 19, 2017 Blood Thinner Pills: Your Guide to Using Them Safely. September 21, 2015 Fentanyl transdermal system (marketed as Duragesic) information. July 10, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. March 11, 2015 Consumer Guide to Adverse Health Events. February 28, 2015 Explicit and Standardized Prescription Medicine Instructions. January 21, 2015 FDA Pharmacists Help Consumers Use Medicines Safely. November 19, 2014 Four Medication Safety Tips for Older Adults. June 18, 2014 OpenFDA. June 11, 2014 Be an Active Member of Your Health Care Team. May 21, 2014 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death. October 9, 2013 Safety Problems With Your Child's Medical Device? July 31, 2013 Critical supply. April 3, 2013 Making Medical Devices Safer at Home. January 9, 2013 View More See More About The Topic Patients Pharmacy Medication Safety Health Literacy Improvement
FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. June 20, 2018
FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. August 5, 2020
FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020
FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020
FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework. April 30, 2014
Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff. August 5, 2015
FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam). June 3, 2015
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018
FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved. January 13, 2016
New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. September 29, 2010
Serious medication errors from intravenous administration of nimodipine oral capsules. August 11, 2010
Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. February 22, 2006
Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020
Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. August 25, 2021
Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry. January 9, 2013
Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. October 3, 2022
FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication November 6, 2019
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019
FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022
Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States. June 23, 2020
Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry. December 23, 2020
Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. April 8, 2009
FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change. January 9, 2005
FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment. June 7, 2006
Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry. May 25, 2022
Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products. January 13, 2021
Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip). June 22, 2011
Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions. January 25, 2017
FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018
Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose. January 19, 2011
Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology. October 21, 2009
Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling. February 16, 2011
FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. March 11, 2015
Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications. March 4, 2015
Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning. March 4, 2015
FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor). August 12, 2015
Important change to heparin container labels to clearly state the total drug strength. December 19, 2012
FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death. October 9, 2013
Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion. May 15, 2013
Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays. November 7, 2012
Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume. May 30, 2012
FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021
Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021
Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022
FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020
Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling. May 19, 2021
Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021
Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. February 17, 2021
The hospital ran out of her child's cancer drug. Now she's fighting to end shortages. November 1, 2023
Medication guides: patient medication information. A proposed rule by the Food and Drug Administration. June 28, 2023
Assessment of patient-preferred language to achieve goal-aligned deprescribing in older adults. June 30, 2021
Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. February 10, 2021
FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020
FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020
Using a spare medication vial to store multiple medications: a potentially fatal in-home medication error. March 6, 2019
All consumer medication information is not created equal: implications for medication safety. April 19, 2017
FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. March 11, 2015
FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death. October 9, 2013